Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK535606PMID: 30601615
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 1254053-43-4
Drug Levels and Effects
Summary of Use during Lactation
No information is available on gilteritinib during breastfeeding. It is 94% bound to plasma proteins, so amounts in milk are likely to be low; however, it has a long half-life of about 113 hours. The manufacturer recommends that breastfeeding be discontinued during gilteritinib therapy and for 2 months after the last dose.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Gilteritinib
CAS Registry Number
1254053-43-4
Drug Class
- Breast Feeding
- Lactation
- Antineoplastic Agents
- Enzyme Inhibitors
- Protein Kinase Inhibitors
- Signal Transduction Inhibitors
- Tyrosine Kinase Inhibitors
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Vandetanib.[Drugs and Lactation Database (...]Review Vandetanib.. Drugs and Lactation Database (LactMed®). 2006
- Review Brigatinib.[Drugs and Lactation Database (...]Review Brigatinib.. Drugs and Lactation Database (LactMed®). 2006
- Review Trametinib.[Drugs and Lactation Database (...]Review Trametinib.. Drugs and Lactation Database (LactMed®). 2006
- Review Osimertinib.[Drugs and Lactation Database (...]Review Osimertinib.. Drugs and Lactation Database (LactMed®). 2006
- Review Bosutinib.[Drugs and Lactation Database (...]Review Bosutinib.. Drugs and Lactation Database (LactMed®). 2006
- Gilteritinib - Drugs and Lactation Database (LactMed®)Gilteritinib - Drugs and Lactation Database (LactMed®)
- Serpinb9g serine (or cysteine) peptidase inhibitor, clade B, member 9g [Mus musc...Serpinb9g serine (or cysteine) peptidase inhibitor, clade B, member 9g [Mus musculus]Gene ID:93806Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...